Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tryptik Ti

K-Number: K200312 · 2020-04-06

ApplicantSpineart
Decision Date2020-04-06
Product CodeODP
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Tryptik Ti is the device name listed in this FDA 510(k) record. The listed applicant is Spineart. It received FDA 510(k) clearance on 2020-04-06 under 510(k) number K200312. The device is classified under product code ODP. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tryptik Ti?

Tryptik Ti is a medical device that received FDA 510(k) clearance on 2020-04-06. The listed applicant is Spineart. The 510(k) number is K200312.

When did Tryptik Ti receive FDA 510(k) clearance?

Tryptik Ti received FDA 510(k) clearance on 2020-04-06, under 510(k) number K200312.

Who is the listed applicant for Tryptik Ti?

The FDA 510(k) record lists Spineart as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Tryptik Ti?

The FDA product code for Tryptik Ti is ODP.

Other records listing Spineart as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 36 devices →

Related Devices (Code: ODP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.